<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Alfresa Holdings Corporation — News on 6ix</title>
    <link>https://6ix.com/company/alfresa-holdings-corporation</link>
    <description>Latest news and press releases for Alfresa Holdings Corporation on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Fri, 19 Sep 2025 12:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/alfresa-holdings-corporation" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d615c0beedb30cb6fbd4ea.webp</url>
      <title>Alfresa Holdings Corporation</title>
      <link>https://6ix.com/company/alfresa-holdings-corporation</link>
    </image>
    <item>
      <title>neffy® (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)</title>
      <link>https://6ix.com/company/alfresa-holdings-corporation/news/neffyr-epinephrine-nasal-spray-approved-in-japan-as-the-first-and-only-needle-free-emergency-treatment-of-allergic-reactions-anaphylaxis</link>
      <guid isPermaLink="true">https://6ix.com/company/alfresa-holdings-corporation/news/neffyr-epinephrine-nasal-spray-approved-in-japan-as-the-first-and-only-needle-free-emergency-treatment-of-allergic-reactions-anaphylaxis</guid>
      <pubDate>Fri, 19 Sep 2025 12:00:00 GMT</pubDate>
      <description>neffy 1 mg and 2 mg doses approved by Japanese regulators neffy offers a new delivery method for epinephrine in Japan for adults and children (&gt;15 kg) living with severe allergic reactions Alfresa Holdings, which owns the rights to market neffy in Japan, expects availability in Q4 2025 SAN DIEGO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves from a</description>
    </item>
  </channel>
</rss>